Lahore urine cultures show Klebsiella remains common, but resistance narrows treatment options
Urinary isolates from a Lahore hospital point to a familiar and increasingly difficult pattern in urinary tract infection management: Enterobacterales remain dominant, and the organisms most likely to force empiric treatment changes are the ones carrying the broadest resistance burden. In this preprint, urine samples from 95 patients with suspected infection were cultured at Lahore General Hospital between July and December 2023. Significant bacterial growth appeared in 63 specimens, or 66.3% of the total. Among the positive cultures, Escherichia coli accounted for 30 isolates, while Klebsiella accounted for 18 isolates, including 16 Klebsiella pneumoniae and two Klebsiella oxytoca.
The finding is clinically important because Klebsiella sits at the intersection of common community infection and hospital-driven antimicrobial pressure. Its polysaccharide capsule, capacity for colonization, and well-documented ability to acquire resistance determinants make it a persistent pathogen in urinary settings, especially where repeated antibiotic exposure is common. In a small hospital cohort like this one, the organism’s share of positive cultures is enough to influence local prescribing habits, particularly when resistance patterns differ sharply from the agents most often used first in routine care.
Susceptibility held strongest for carbapenems and nitrofurantoin
Susceptibility testing was performed across 18 Klebsiella isolates for each antibiotic. The clearest signal emerged with the carbapenems: imipenem and meropenem each showed activity against 17 of 18 isolates. Nitrofurantoin followed closely, with susceptibility in 16 of 18 isolates. Those results suggest that, within this setting, the most reliable in vitro options remained the agents traditionally reserved for more resistant gram-negative infections, alongside a urinary antiseptic that still retained meaningful activity against most isolates.
One sentence captures the central dilemma: the strongest drugs were also the ones that should be protected.
Resistance to several cephalosporins, fluoroquinolones, and aminoglycosides was frequent. Even without a full species-by-species resistance matrix for every antibiotic, the pattern is enough to raise concern about the durability of standard empiric choices. In practical terms, if a local antibiogram begins to resemble this profile, the usual oral and parenteral agents used for uncomplicated and complicated urinary infection lose reliability, and clinicians are pushed toward narrower empiric confidence or more rapid culture-guided adjustment.
Age and sex distribution suggest a broad community burden
Klebsiella was recovered from 12 female patients and six male patients. The largest number of Klebsiella isolates occurred in patients aged 21 to 30 years. Those demographic details do not establish a causal risk factor profile, but they do show that this was not confined to frail inpatients or older adults alone. A younger adult predominance can reflect patterns of healthcare seeking, prior antibiotic exposure, community transmission, sexual health-related urinary symptoms, or local referral behavior; the dataset does not resolve which mechanism dominated.
Still, the bedside consequence is straightforward. When a younger outpatient population carries a meaningful burden of resistant urinary gram-negative infection, assumptions about “simple cystitis” become less dependable. Empiric therapy based on older susceptibility expectations can miss the mark, and even short treatment delays matter when symptoms are severe or when infection ascends.
The microbiology supports caution, not policy change
This was a small hospital sample, and the study itself flags the need for larger work with verified species-specific susceptibility data before any local treatment policy is rewritten. That caution is appropriate. A sample of 18 Klebsiella isolates cannot define a citywide antibiogram, and a single-center preprint cannot distinguish persistent colonization from recurrent infection, community acquisition from healthcare-associated acquisition, or one-time clustering from stable endemic resistance.
Even so, the microbiology is hard to ignore. When Klebsiella shows high susceptibility to carbapenems but frequent resistance to cephalosporins, fluoroquinolones, and aminoglycosides, the likely explanation is cumulative antimicrobial selection pressure acting on an organism that readily acquires beta-lactamases and other resistance mechanisms. In that setting, the rise of carbapenem activity in the data is not reassuring so much as it is a reminder that treatment options are contracting upward, toward broader-spectrum agents that are costlier, more stewardship-sensitive, and less desirable as routine empiric choices.
Why the local data matter for stewardship in Pakistan
The value of the study lies less in any single percentage than in the way it frames local decision-making. Urinary isolates are not interchangeable across regions, hospitals, or even seasons. Antibiotic susceptibility can shift with prescribing pressure, access to over-the-counter treatment, patient referral pathways, and infection-control practices. In Lahore, these data argue for routine culture before escalation whenever feasible, especially when suspected infection is not clinically mild or when prior antibiotic exposure has already occurred.
The public health message is also practical. A setting that relies on cephalosporins or fluoroquinolones without current local susceptibility data risks repeated treatment failure and prolonged bacterial carriage. That cycle feeds repeat visits, repeat prescriptions, and wider resistance selection. By contrast, a local surveillance program anchored in current urine culture results can identify when nitrofurantoin remains useful for selected lower urinary infections and when broader therapy is truly necessary.
Preprint status leaves the key question unanswered
Because this study is a preprint and has not undergone peer review, the findings should be treated as preliminary. The work does not provide a citywide prevalence estimate, nor does it establish whether the observed resistance profile is stable over time. It also does not report patient-level clinical outcomes, prior antibiotic exposure, or detailed species-specific resistance by isolate in a way that would support a formal treatment algorithm.
The next step is clear in clinical terms, even if the answer is still incomplete: larger, peer-reviewed surveillance with consistent susceptibility methods is needed to determine whether Lahore should reconsider its default empiric choices for urinary infection. Until then, the safest interpretation is measured and direct. Klebsiella is a meaningful urinary pathogen in this cohort, and the organism’s resistance profile leaves little room for complacency.
- • medRxiv Preprint DOI 10.64898/2026.11.15.26368163: https://doi.org/10.64898/2026.11.15.26368163